Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia

Phase

N/A

Condition

Diabetes Prevention

Smoking Cessation

Treatment

8 weeks of Nicotine Replacement Therapy Patch

8 Weeks Nicotine Lozenge

4 weeks of Nicotine lozenge

Clinical Study ID

NCT05660525

HSR220197

Ages > 18
All Genders
Accepts Healthy Volunteers

Study Summary

The goal of this clinical trial is to evaluate the effectiveness and implementation of a pharmacist-delivered MTM (medication therapy management) approach, called QuitAid, to quitting cigarette smoking in rural Appalachia.

The main questions it aims to answer are:

Is QuitAid, alone or combined with other quitting tobacco treatments, effective?
What makes QuitAid easy or hard to carry out? Is it cost effective? Is it easy to maintain?

Treatment:

All participants will be given at least 4 weeks of the nicotine patch.

Some participants will be randomized (like the flip of a coin) to receive additional treatments (listed below).

These groups will be compared to each other to see which combination works best to help them quit smoking.

Smokefree TXT - a texting program that helps people quit smoking
Tobacco quitline - 4 phone sessions to help people quit smoking
8 weeks of NRT (nicotine replacement therapy in the form of nicotine patches or nicotine patches and lozenge) medication instead of 4 weeks
QuitAid - An MTM program given by the patient's pharmacist. This is a quitting smoking coaching program
Nicotine patch AND nicotine lozenge instead of just nicotine patches

Eligibility Criteria

Inclusion

Study participants will be rural cigarette smokers from Virginia, Tennessee, Kentucky and North Carolina who visit one of the participating study pharmacies. Pharmacies will be located in rural geographic areas of the Central and South Central subregions of Appalachia that include Virginia, Tennessee, Kentucky and North Carolina, as defined by the USDA Rural-Urban Continuum Codes (RUCC) 4-9, Rural-Urban Commuting Area (RUCA) codes 4-10, or Frontier and Remote (FAR) areas level 4. No exclusionary criteria are based on race, gender, or age.

Inclusion Criteria include:

must be 18 years of age and older
must be able to read, speak, and understand English
must report smoking at least 5 cigarettes per day for the past 6 months (regardless of non-cigarette tobacco product use)
must be willing to set a quit date within the next 30 days
must own a cell phone
must be willing and able to use NRT in the form of patch or lozenge
Not be pregnant or planning to be pregnant in the next 6 months.

Exclusion Criteria include:

are pregnant women (self-reported), breastfeeding, planning to become pregnant during the next 6 months
have a medical contraindication to NRT (e.g., past 30 days, heart attack or stroke; past 6 months, serious or worsening angina, very rapid or irregular heartbeat requiring medication)

Study Design

8 weeks of Nicotine Replacement Therapy Patch

March 06, 2024

March 01, 2028

Study Description

The proposed study uses a mixed-method design to evaluate the effectiveness and implementation of a pharmacist-delivered MTM (Medication Therapy Management) approach, called QuitAid, to smoking cessation in rural Appalachia. Aim 1 of this project will evaluate the effectiveness of QuitAid and standard, evidence-based tobacco treatments on cessation within an MTM pharmacist-delivered approach. Aim 2 will assess implementation, including relative cost of QuitAid, as well as standard, evidence-based tobacco treatments through an ask-advise-connect model, in community pharmacies, and will examine facilitators and barriers to reach, adoption, and maintenance of QuitAid as well as standard, evidence-based tobacco treatments through an ask-advise-connect method in community pharmacies.

Smokers (n=768) recruited through 14 community pharmacies in rural Appalachia will be randomized in a 2x2x2x2x2 full factorial experiment to the following five treatments: (1) QuitAid Intervention (Yes vs. No), (2) tobacco quitline (Yes vs. No), (3) SmokefreeTXT through the National Cancer Institute's (NCI) Smokefree.gov initiative (Yes vs. No), (4) Combination NRT Lozenge + NRT Patch (vs. NRT patch alone), and/or (5) 8 weeks of NRT (vs. standard 4 weeks). Following the experimental trial, we will use an implementation science approach to assess implementation, including relative cost, as well as facilitators and barriers of reach, adoption, and maintenance of QuitAid and standard, evidence-based tobacco treatments through an ask-advise-connect method in community pharmacies (Aim 2).

Connect with a study center

University of Virginia
Charlottesville, Virginia 22904
United States
Site Not Available
University of Virginia
Charlottesville 4752031, Virginia 6254928 22904
United States
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.